Spots Global Cancer Trial Database for rectal
Every month we try and update this database with for rectal cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Radiation Dosimetry Study Comparing 2 Different Patient Setups in Anal/Rectal Cancer Patients | NCT00693173 | Anal Cancer | 18 Years - 80 Years | The University of Texas Medical Branch, Galveston | ||
| Clinical And Translational Study Of MK-2206 In Patients With Metastatic KRAS-Wild-Type, PIK3CA-Mutated, Colorectal Cancer | NCT01186705 | Colon Cancer Rectal Cancer | MK-2206 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer | NCT00200200 | Hepatic Metasta... Colon Cancer Rectal Cancer | Bevacizumab HAI... HAI plus system... | 19 Years - | Memorial Sloan Kettering Cancer Center | |
| Prospective Validation Study for the Proprietary Rectal and Anal Cancer Protein Expression Assays | NCT02407561 | Rectal Adenocar... Anal Adenocarci... Anal Squamous C... | 18 Years - | Castle Biosciences Incorporated | ||
| Preoperative Valproic Acid and Radiation Therapy for Rectal Cancer | NCT01898104 | Colorectal Canc... | preoperative ra... Valproic Acid Capecitabine | 18 Years - 70 Years | National Cancer Institute, Naples | |
| Tertiary Prevention by Exercise in Colorectal Cancer Therapy | NCT01991847 | Colorectal Canc... | Physical activi... | 40 Years - 80 Years | Technical University of Munich | |
| Pilot Study of Strength and Balance Training Program for Persons With Oxaliplatin Induced Neuropathy | NCT01422993 | Neuropathy Gastrointestina... | 12 Week Exercis... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Concordance of Imaging and Pathology Diagnosis of Extranodal Tumour Deposits | NCT03303547 | Adenocarcinoma ... | MRI mapping to ... | 16 Years - | Imperial College London | |
| Prospective Validation Study for the Proprietary Rectal and Anal Cancer Protein Expression Assays | NCT02407561 | Rectal Adenocar... Anal Adenocarci... Anal Squamous C... | 18 Years - | Castle Biosciences Incorporated | ||
| A Study of Fruquintinib in Combination With Tislelizumab in Advanced Solid Tumors | NCT04577963 | Triple Negative... Endometrial Can... Solid Tumor, Un... Colorectal Canc... | Fruquintinib Tislelizumab | 18 Years - | Hutchmed | |
| Determination of Microbiological Factors Associated With Poor Response to Neoadjuvant Treatment in Rectal Cancers | NCT04103567 | Rectal Cancer | Biological coll... | 18 Years - | Institut du Cancer de Montpellier - Val d'Aurelle | |
| A Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer | NCT00483834 | Colorectal Canc... | Bevacizumab Irinotecan Capecitabine | 18 Years - | University Health Network, Toronto | |
| Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type RAS Who Have Resected Hepatic Metastases From Colorectal Cancer | NCT01312857 | Metastatic Colo... | panitumumab Randomization t... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Cross-linked Hyaluronan Gel Reduces Rectal Toxicity Due to Radiation Therapy for Prostate Cancer | NCT00882232 | Prostate Cancer | Cross-linked hy... | 18 Years - | Cancer Center of Irvine | |
| EPO906 Therapy in Patients With Advanced Colorectal Cancer | NCT00035087 | Colorectal Neop... Colonic Neoplas... | epothilone b | 18 Years - 85 Years | Novartis | |
| Focusing Implementation to Bring Effective Reminders (FIBER) | NCT00656838 | Colorectal Canc... | Patients receiv... | 50 Years - 80 Years | Kaiser Permanente | |
| Preoperative Chemoradiation With Capecitabine and Cetuximab | NCT00297128 | Rectal Cancer | Capecitabine Cetuximab | 18 Years - 80 Years | Austrian Breast & Colorectal Cancer Study Group | |
| Rifaximin and Placebo in the Treatment of Bowel Dysfunction After Anterior Resection for Rectal Cancer | NCT01345175 | Rectal Cancer | Rifaximin Placebo | 21 Years - | Memorial Sloan Kettering Cancer Center | |
| A Study of Fruquintinib in Combination With Tislelizumab in Advanced Solid Tumors | NCT04577963 | Triple Negative... Endometrial Can... Solid Tumor, Un... Colorectal Canc... | Fruquintinib Tislelizumab | 18 Years - | Hutchmed | |
| Clinical and Translational Study of STA-9090 | NCT01111838 | Colon Cancer Rectal Cancer | STA-9090 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Preoperative Combined RadioChemo-Molecular Target Therapy With Capecitabine, Bevacizumab, and Radiotherapy | NCT00671645 | Rectal Cancer | capecitabine, b... | 18 Years - 80 Years | Austrian Breast & Colorectal Cancer Study Group | |
| Preoperative Chemoradiation With Capecitabine and Cetuximab | NCT00297128 | Rectal Cancer | Capecitabine Cetuximab | 18 Years - 80 Years | Austrian Breast & Colorectal Cancer Study Group | |
| Clinical and Translational Study of STA-9090 | NCT01111838 | Colon Cancer Rectal Cancer | STA-9090 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Study of Capecitabine With Irinotecan and Oxaliplatin (Eloxatin) in Advanced Colorectal Cancer | NCT00215982 | Colorectal Canc... | capecitabine Oxaliplatin Irinotecan | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Study of SQZ-PBMC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors | NCT04084951 | Adult Solid Tum... | SQZ-PBMC-HPV Atezolizumab Ipilimumab Nivolumab | 18 Years - | SQZ Biotechnologies | |
| Tertiary Prevention by Exercise in Colorectal Cancer Therapy | NCT01991847 | Colorectal Canc... | Physical activi... | 40 Years - 80 Years | Technical University of Munich | |
| Clinical and Translational Study of STA-9090 | NCT01111838 | Colon Cancer Rectal Cancer | STA-9090 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Genotype-directed Neoadjuvant Chemoradiation for Rectal Carcinoma | NCT00682786 | Rectal Carcinom... | 5FU Radiation Surgery of rese... Irinotecan | 18 Years - | Washington University School of Medicine | |
| Total Neoadjuvant Therapy With mFOLFOX and Short-course Radiation in Resectable Rectal Cancer | NCT04643366 | Rectal Cancer | Chemotherapy Radiation Thera... | 18 Years - | Virginia Commonwealth University | |
| Genotype-directed Neoadjuvant Chemoradiation for Rectal Carcinoma | NCT00682786 | Rectal Carcinom... | 5FU Radiation Surgery of rese... Irinotecan | 18 Years - | Washington University School of Medicine | |
| Determination of Microbiological Factors Associated With Poor Response to Neoadjuvant Treatment in Rectal Cancers | NCT04103567 | Rectal Cancer | Biological coll... | 18 Years - | Institut du Cancer de Montpellier - Val d'Aurelle | |
| Clinical Database of Colorectal Robotic Surgery | NCT04013152 | Crohn Disease Polyposis Ulcerative Coli... Diverticulitis Colorectal Tumo... Rectal Prolapse Benign Colorect... | Clinical databa... | 18 Years - | Institut du Cancer de Montpellier - Val d'Aurelle | |
| Preoperative Valproic Acid and Radiation Therapy for Rectal Cancer | NCT01898104 | Colorectal Canc... | preoperative ra... Valproic Acid Capecitabine | 18 Years - 70 Years | National Cancer Institute, Naples | |
| Family Colorectal Cancer Awareness and Risk Education Project (Family CARE Project) | NCT01274143 | Colorectal Canc... | TeleCARE Pamphlet interv... | 30 Years - 74 Years | University of Utah | |
| Maximizing Yield of the Fecal Immunochemical Test for Colorectal Cancer Screening | NCT01634126 | Colorectal Canc... | 1 FIT kit 2 FIT kit | 50 Years - 75 Years | Kaiser Permanente | |
| Clinical And Translational Study Of MK-2206 In Patients With Metastatic KRAS-Wild-Type, PIK3CA-Mutated, Colorectal Cancer | NCT01186705 | Colon Cancer Rectal Cancer | MK-2206 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Determination of Microbiological Factors Associated With Poor Response to Neoadjuvant Treatment in Rectal Cancers | NCT04103567 | Rectal Cancer | Biological coll... | 18 Years - | Institut du Cancer de Montpellier - Val d'Aurelle |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
